Non-Invasive Treatment for Tumors With Iranian Device
In an interview with Iranian media, Zeinab Shenghaie, a professor at Tehran-based Baqiyatallah University of Medical Sciences and the managing director of a technological company revealed the knowledge-oriented product of her company called it the "Electroporation" device.
“Electroporation introduces electric pulses and electrical fields in the cell membrane after creating a hole,” she said, calling the device a revolutionary technology which allows efficient and effective introduction of substances such as drugs and chemical as well as electrode arrays into the cells.
She explained that the electroporation which is also called electrotransfer is used in to different ways. It is used in the fields of biotechnology and biochemistry to transfer macromolecules (macromolecules) such as DNA and RNA, which had been produced with their parts in their company.
Shenghaie said that the device has a clinical use as well, adding, “This device is used for cancer treatment along with chemotherapy drugs and we have obtained permission for clinical trials of this device for curing tumor with it in some hospitals."
“We have received a permission to use the device temporarily; we are in phase 2 and 3 of clinical trials," she said.
Regarding the therapeutic applications of this device, the managing director of the technical company explained, "This device allows the cell membrane, which has not been permeable to the drug, to become permeable, and then the drug with high toxicity It enters the body and immediately the drug gets stuck inside the tumor cell."
According to the researcher, another advantage of their device is that it allows the drug to be injected at the location of the tumor.
Emphasizing that the initial device made in their company is only used for the treatment of superficial tumors such as rectal and pelvic tumors, the project manager continued, "With this device, chemical drugs are injected inside the tumor.”
"In order to complete the treatment of tumors, we designed another device that has entered the clinical trial phase and through which we have provided access to deep tumors," the project manager went on to say.
4155/i
